Stephen Maxted Ansell, MD, PhD

  • 20939 Citations
  • 77 Scopus h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1983 2019

2012
25 Citations (Scopus)

IL-21 in the bone marrow microenvironment contributes to IgM secretion and proliferation of malignant cells in Waldenstrom macroglobulinemia

Hodge, L. S., Ziesmer, S. C., Yang, Z. Z., Secreto, F. J., Gertz, M., Novak, A. J. & Ansell, S. M., Nov 1 2012, In : Blood. 120, 18, p. 3774-3782 9 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Immunoglobulin M
Bone
Bone Marrow
Cell Proliferation
79 Citations (Scopus)

Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): A single-center experience

D'Souza, A., Lacy, M., Gertz, M., Kumar, S. K., Buadi, F., Hayman, S., Dingli, D. M., Zeldenrust, S., Kyle, R., Ansell, S. M., Inwards, D., Johnston, P. B., Micallef, I., Porrata, L., Litzow, M. R., Gastineau, D., Hogan, W. & Dispenzieri, A., Jul 5 2012, In : Blood. 120, 1, p. 56-62 7 p.

Research output: Contribution to journalArticle

POEMS Syndrome
Stem Cell Transplantation
Stem cells
Hazards
Confidence Intervals
18 Citations (Scopus)

Molecular pathogenesis of Waldenström's macroglobulinemia

Braggio, E. D., Philipsborn, C., Novak, A. J., Hodge, L., Ansell, S. M. & Fonseca, R., Sep 1 2012, In : Haematologica. 97, 9, p. 1281-1290 10 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Immunoglobulin M
Biomarkers
Bone Marrow
Research
43 Citations (Scopus)

MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma

Ramakrishnan, V., Ansell, S. M., Haug, J., Grote, D., Kimlinger, T., Stenson, M., Timm, M., Wellik, L., Halling, T., Rajkumar, S. V. & Kumar, S. K., Feb 2012, In : Leukemia. 26, 2, p. 340-348 9 p.

Research output: Contribution to journalArticle

Amyloid Precursor Protein Secretases
Multiple Myeloma
Non-Hodgkin's Lymphoma
Notch Receptors
Cell Line
131 Citations (Scopus)

Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma

Porrata, L. F., Ristow, K., Colgan, J. P., Habermann, T. M., Witzig, T. E., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Nowakowski, G. S., Thompson, C. A. & Markovic, S. N., Feb 1 2012, In : Haematologica. 97, 2, p. 262-269 8 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Lymphocyte Count
Monocytes
Lymphocytes
Confidence Intervals
51 Citations (Scopus)
Hodgkin Disease
Monocytes
Lymphocytes
Survival
Confidence Intervals
36 Citations (Scopus)

Positron emission tomographic scans in lymphoma: Convention and controversy

Ansell, S. M. & Armitage, J. O., 2012, In : Mayo Clinic Proceedings. 87, 6, p. 571-580 10 p.

Research output: Contribution to journalArticle

Lymphoma
Positron-Emission Tomography
Electrons
Hodgkin Disease
Follicular Lymphoma
36 Citations (Scopus)

Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: A clinic-based case-control study

Charbonneau, B., Maurer, M. J., Ansell, S. M., Slager, S. L., Fredericksen, Z. S., Ziesmer, S. C., Macon, W. R., Habermann, T. M., Witzig, T. E., Link, B. K., Cerhan, J. R. & Novak, A. J., Dec 2012, In : Cytokine. 60, 3, p. 882-889 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Case-Control Studies
B-Lymphocytes
Cells
Cytokines
19 Citations (Scopus)

PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: Results from the InterLymph consortium

Nieters, A., Conde, L., Slager, S. L., Brooks-Wilson, A., Morton, L., Skibola, D. R., Novak, A. J., Riby, J., Ansell, S. M., Halperin, E., Shanafelt, T. D., Agana, L., Wang, A. H., De Roos, A. J., Severson, R. K., Cozen, W., Spinelli, J., Butterbach, K., Becker, N., De Sanjose, S. & 23 others, Benavente, Y., Cocco, P., Staines, A., Maynadié, M., Foretova, L., Boffetta, P., Brennan, P., Lan, Q., Zhang, Y., Zheng, T., Purdue, M., Armstrong, B., Kricker, A., Vajdic, C. M., Grulich, A., Smith, M. T., Bracci, P. M., Chanock, S. J., Hartge, P., Cerhan, J. R., Wang, S. S., Rothman, N. & Skibola, C. F., Nov 29 2012, In : Blood. 120, 23, p. 4645-44648 40004 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
B-Cell Lymphoma
Genes
Cells
B-Lymphocytes
847 Citations (Scopus)

Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma

Younes, A., Gopal, A. K., Smith, S. E., Ansell, S. M., Rosenblatt, J. D., Savage, K. J., Ramchandren, R., Bartlett, N. L., Cheson, B. D., De Vos, S., Forero-Torres, A., Moskowitz, C. H., Connors, J. M., Engert, A., Larsen, E. K., Kennedy, D. A., Sievers, E. L. & Chen, R., Jun 20 2012, In : Journal of Clinical Oncology. 30, 18, p. 2183-2189 7 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Stem Cell Transplantation
cAC10-vcMMAE
Safety
Antibodies
28 Citations (Scopus)

Stem cell transplant for Waldenström macroglobulinemia: An underutilized technique

Gertz, M., Reeder, C. B., Kyle, R. A. & Ansell, S. M., Sep 2012, In : Bone Marrow Transplantation. 47, 9, p. 1147-1153 7 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Stem Cells
Autografts
Transplants
Multiple Myeloma
25 Citations (Scopus)

t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growth

Ansell, S. M., Akasaka, T., McPhail, E., Manske, M., Braggio, E. D., Price-Troska, T., Ziesmer, S., Secreto, F., Fonseca, R., Gupta, M., Law, M., Witzig, T. E., Dyer, M. J. S., Dogan, A., Cerhan, J. R. & Novak, A. J., Nov 8 2012, In : Blood. 120, 19, p. 3949-3957 9 p.

Research output: Contribution to journalArticle

Marginal Zone B-Cell Lymphoma
Cell growth
Tumors
Lymphoma
Growth
64 Citations (Scopus)

The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma

Wilcox, R. A., Ristow, K., Habermann, T. M., Inwards, D. J., Micallef, I., Johnston, P. B., Colgan, J. P., Nowakowski, G. S., Ansell, S. M., Witzig, T. E., Markovic, S. N. & Porrata, L., Apr 2012, In : Leukemia and Lymphoma. 53, 4, p. 575-580 6 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Monocytes
Survival
Spontaneous Remission
Tumor Microenvironment
12 Citations (Scopus)

The B7 Homologues and their Receptors in Hematologic Malignancies

Wilcox, R. A., Ansell, S. M., Lim, M. S., Zou, W. & Chen, L., Jun 2012, In : European Journal of Haematology. 88, 6, p. 465-475 11 p.

Research output: Contribution to journalArticle

Hematologic Neoplasms
Peripheral Tolerance
Adaptive Immunity
Immunity
Neoplasms
19 Citations (Scopus)

The tumor microenvironment in follicular lymphoma

Yang, Z. Z. & Ansell, S. M., Dec 2012, In : Clinical Advances in Hematology and Oncology. 10, 12, p. 810-818 9 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Tumor Microenvironment
B-Lymphocytes
Cellular Microenvironment
Gene Expression Profiling
2011
3 Citations (Scopus)
Continuing Medical Education
Risk Management
Hematologic Neoplasms
Hodgkin Disease
Drug Therapy
234 Citations (Scopus)

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

Witzig, T. E., Reeder, C. B., Laplant, B. R., Gupta, M., Johnston, P. B., Micallef, I., Porrata, L. F., Ansell, S. M., Colgan, J. P., Jacobsen, E. D., Ghobrial, I. M. & Habermann, T. M., Feb 2011, In : Leukemia. 25, 2, p. 341-347 7 p.

Research output: Contribution to journalArticle

Lymphoma
Non-Hodgkin's Lymphoma
Phosphatidylinositol 3-Kinase
Raptors
Sirolimus
66 Citations (Scopus)
Integrin alpha4beta1
B-Cell Lymphoma
Mesenchymal Stromal Cells
Integrins
Apoptosis
24 Citations (Scopus)

Brentuximab vedotin: Delivering an antimitotic drug to activated lymphoma cells

Ansell, S. M., Jan 2011, In : Expert Opinion on Investigational Drugs. 20, 1, p. 99-105 7 p.

Research output: Contribution to journalArticle

Antimitotic Agents
Anaplastic Large-Cell Lymphoma
Lymphoma
Hodgkin Disease
Lymphoproliferative Disorders
27 Citations (Scopus)

CD40 pathway activation status predicts response to CD40 therapy in diffuse large B cell lymphoma

Burington, B., Yue, P., Shi, X., Advani, R., Lau, J. T., Tan, J., Stinson, S., Stinson, J., Januario, T., De Vos, S., Ansell, S. M., Forero-Torres, A., Fedorowicz, G., Yang, T. T. C., Elkins, K., Du, C., Mohan, S., Yu, N., Modrusan, Z., Seshagiri, S. & 9 others, Yu, S. F., Pandita, A., Koeppen, H., French, D., Polson, A. G., Offringa, R., Whiting, N., Ebens, A. & Dornan, D., Mar 16 2011, In : Science Translational Medicine. 3, 74, 74ra22.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Immunoglobulin Class Switching
Cell Line
B-Lymphocytes
Neoplasms
49 Citations (Scopus)

Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity

Elsawa, S. F., Novak, A. J., Ziesmer, S. C., Almada, L. L., Hodge, L. S., Grote, D. M., Witzig, T. E., Fernandez-Zapico, M. E. & Ansell, S. M., Nov 17 2011, In : Blood. 118, 20, p. 5540-5549 10 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Tumor Microenvironment
Modulators
Immunoglobulin M
Tumors
29 Citations (Scopus)

Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma

Cerhan, J. R., Fredericksen, Z. S., Wang, A. H., Habermann, T. M., Kay, N. E., Macon, W. R., Cunningham, J. M., Shanafelt, T. D., Ansell, S. M., Call, T. G., Witzig, T. E., Slager, S. L. & Liebow, M., 2011, In : International Journal of Molecular Epidemiology and Genetics. 2, 2, p. 95-113 19 p.

Research output: Contribution to journalArticle

Molecular Epidemiology
Case-Control Studies
Lymphoma
Single Nucleotide Polymorphism
Smoking
179 Citations (Scopus)

Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing

Feldman, A. L., Dogan, A., Smith, D. I., Law, M. E., Ansell, S. M., Johnson, S. H., Porcher, J. C., Özsan, N., Wieben, E. D., Eckloff, B. W. & Vasmatzis, G., Jan 20 2011, In : Blood. 117, 3, p. 915-919 5 p.

Research output: Contribution to journalArticle

Anaplastic Large-Cell Lymphoma
High-Throughput Nucleotide Sequencing
T-cells
Bioinformatics
MicroRNAs
50 Citations (Scopus)

Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma

Maurer, M. J., Micallef, I., Cerhan, J. R., Katzmann, J. A., Link, B. K., Colgan, J. P., Habermann, T. M., Inwards, D. J., Markovic, S. N., Ansell, S. M., Porrata, L. F., Johnston, P. B., Nowakowski, G. S., Thompson, C. A., Gupta, M., Syrbu, S. I., Kurtin, P. J., Macon, W. R., Nikcevich, D. A. & Witzig, T. E., Apr 20 2011, In : Journal of Clinical Oncology. 29, 12, p. 1620-1626 7 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Disease-Free Survival
Light
Serum
Survival
23 Citations (Scopus)

Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma

Thompson, C. A., Maurer, M. J., Cerhan, J. R., Katzmann, J. A., Ansell, S. M., Habermann, T. M., Macon, W. R., Weiner, G. J., Link, B. K. & Witzig, T. E., Dec 2011, In : American Journal of Hematology. 86, 12, p. 998-1000 3 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Disease-Free Survival
Light
Serum
Immunoglobulin lambda-Chains
29 Citations (Scopus)

Establishment and characterization of a novel Waldenström macroglobulinemia cell line, MWCL-1

Hodge, L. S., Novak, A. J., Grote, D. M., Braggio, E. D., Ketterling, R. P., Manske, M. K., Price Troska, T. L., Ziesmer, S. C., Fonseca, R., Witzig, T. E., Morice, W. G., Gertz, M. & Ansell, S. M., May 12 2011, In : Blood. 117, 19

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Tumors
Cells
Cell Line
Tumor Cell Line
27 Citations (Scopus)

GLI2 transcription factor mediates cytokine cross-talk in the tumor microenvironment

Elsawa, S. F., Almada, L. L., Ziesmer, S. C., Novak, A. J., Witzig, T. E., Ansell, S. M. & Fernandez-Zapico, M. E., Jun 17 2011, In : Journal of Biological Chemistry. 286, 24, p. 21524-21534 11 p.

Research output: Contribution to journalArticle

Tumor Microenvironment
Tumors
Transcription Factors
Cells
Cytokines
4 Citations (Scopus)

Identifying patients with follicular lymphoma who are likely to benefit from an idiotype vaccine

Ansell, S. M. & Suman, V. J., Jul 10 2011, In : Journal of Clinical Oncology. 29, 20, p. 2748-2749 2 p.

Research output: Contribution to journalArticle

Immunoglobulin Idiotypes
Follicular Lymphoma
Cancer Vaccines
Patient Selection
Vaccines

Innate immune B cells gone bad

Ansell, S. M., Nov 7 2011, In : Oncology. 25, 12

Research output: Contribution to journalArticle

B-Lymphocytes

Innate immune B cells gone bad.

Ansell, S. M., Nov 15 2011, In : Oncology (Williston Park, N.Y.). 25, 12

Research output: Contribution to journalArticle

Marginal Zone B-Cell Lymphoma
B-Lymphocytes
13 Citations (Scopus)

Jak/stat pathway in Waldenström's macroglobulinemia

Hodge, L. S. & Ansell, S. M., Feb 1 2011, In : Clinical Lymphoma, Myeloma and Leukemia. 11, 1, p. 112-114 3 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Immunoglobulin M
Cytokines
Autocrine Communication
Paracrine Communication
81 Citations (Scopus)

Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: Phase i study

Nowakowski, G. S., Laplant, B., Habermann, T. M., Rivera, C. E., MacOn, W. R., Inwards, D. J., Micallef, I., Johnston, P. B., Porrata, L. F., Ansell, S. M., Klebig, R. R., Reeder, C. B. & Witzig, T. E., Dec 2011, In : Leukemia. 25, 12, p. 1877-1881 5 p.

Research output: Contribution to journalArticle

Vincristine
B-Cell Lymphoma
Prednisone
Doxorubicin
Cyclophosphamide
5 Citations (Scopus)

Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization

Naina, H. V., Pruthi, R. K., Inwards, D. J., Dingli, D. M., Litzow, M. R., Ansell, S. M., Hogan, W., Dispenzieri, A., Buadi, F. K., Elliott, M. A., Gastineau, D. A., Gertz, M., Hayman, S. R., Johnston, P. B., Lacy, M., Micallef, I., Porrata, L. F. & Kumar, S. K., Feb 2011, In : Bone Marrow Transplantation. 46, 2, p. 291-293 3 p.

Research output: Contribution to journalArticle

Intercellular Signaling Peptides and Proteins
Granulocytes
Thrombosis
Amyloidosis
Multiple Myeloma
13 Citations (Scopus)

MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterparts

Hodge, L. S., Elsawa, S. F., Grote, D. M., Price-Troska, T. L., Asmann, Y., Fonseca, R., Gertz, M., Witzig, T. E., Novak, A. J. & Ansell, S. M., Jun 2011, In : Blood Cancer Journal. 1, 6, e24.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
MicroRNAs
Neoplasms
B-Lymphocytes
Hematopoiesis
30 Citations (Scopus)

Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas

Witzig, T. E., Tang, H., Micallef, I., Ansell, S. M., Link, B. K., Inwards, D. J., Porrata, L. F., Johnston, P. B., Colgan, J. P., Markovic, S. N., Nowakowski, G. S., Thompson, C. A., Allmer, C., Maurer, M. J., Gupta, M., Weiner, G., Hohl, R., Kurtin, P. J., Ding, H., Loegering, D. & 4 others, Schneider, P., Peterson, K., Habermann, T. M. & Kaufmann, S. H., Nov 3 2011, In : Blood. 118, 18, p. 4882-4889 8 p.

Research output: Contribution to journalArticle

tipifarnib
Farnesyltranstransferase
Refractory materials
Non-Hodgkin's Lymphoma
Lymphoma
37 Citations (Scopus)

Novel therapeutic agents for B-cell lymphoma: Developing rational combinations

Reeder, C. B. & Ansell, S. M., Feb 3 2011, In : Blood. 117, 5, p. 1453-1462 10 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Cells
Critical Pathways
Tumor Microenvironment
46 Citations (Scopus)

Predicting PBSC harvest failure using circulating CD34 levels: Developing target-based cutoff points for early intervention

Sinha, S., Gastineau, D., Micallef, I., Hogan, W., Ansell, S. M., Buadi, F., Dingli, D. M., Dispenzieri, A., Gertz, M., Greiner, C., Hayman, S., Inwards, D., Johnston, P. B., Lacy, M., Litzow, M. R., Porrata, L., Winters, J. L. & Kumar, S. K., Jul 2011, In : Bone Marrow Transplantation. 46, 7, p. 943-949 7 p.

Research output: Contribution to journalArticle

Granulocyte Colony-Stimulating Factor
Hodgkin Disease
Non-Hodgkin's Lymphoma
Blood Component Removal
Amyloidosis
32 Citations (Scopus)

Programmed death 1 is expressed in cutaneous infiltrates of mycosis fungoides and Sézary syndrome

Wada, D. A., Wilcox, R. A., Harrington, S. M., Kwon, E. D., Ansell, S. M. & Comfere, N. I., Mar 2011, In : American Journal of Hematology. 86, 3, p. 325-327 3 p.

Research output: Contribution to journalArticle

Neoplasm Proteins
CD Antigens
Sezary Syndrome
Mycosis Fungoides
Apoptosis Regulatory Proteins
71 Citations (Scopus)

Soluble IL-2Rα facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma

Yang, Z. Z., Grote, D. M., Ziesmer, S. C., Manske, M. K., Witzig, T. E., Novak, A. J. & Ansell, S. M., Sep 8 2011, In : Blood. 118, 10, p. 2809-2820 12 p.

Research output: Contribution to journalArticle

Interleukin-2 Receptors
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Interleukin-2
T-cells
97 Citations (Scopus)

Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: A multicenter study of 204 skin biopsies

Wada, D. A., Law, M. E., Hsi, E. D., Dicaudo, D. J., Ma, L., Lim, M. S., De Souza, A., Comfere, N. I., Weenig, R. H., MacOn, W. R., Erickson, L. A., Özsan, N., Ansell, S. M., Dogan, A. & Feldman, A. L., Apr 2011, In : Modern Pathology. 24, 4, p. 596-605 10 p.

Research output: Contribution to journalArticle

Primary Cutaneous Anaplastic Large Cell Lymphoma
Anaplastic Large-Cell Lymphoma
Multicenter Studies
Lymphoproliferative Disorders
Biopsy
122 Citations (Scopus)

Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: A phase 2 study

Ansell, S. M., Tang, H., Kurtin, P. J., Koenig, P. A., Inwards, D. J., Shah, K., Ziesmer, S. C., Feldman, A. L., Rao, R., Gupta, M., Erlichman, C. & Witzig, T. E., Apr 2011, In : The Lancet Oncology. 12, 4, p. 361-368 8 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Sirolimus
temsirolimus
Rituximab
Pneumonia
114 Citations (Scopus)

The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma

Wilcox, R. A., Ristow, K., Habermann, T. M., Inwards, D. J., Micallef, I., Johnston, P. B., Colgan, J. P., Nowakowski, G. S., Ansell, S. M., Witzig, T. E., Markovic, S. N. & Porrata, L., Sep 2011, In : Leukemia. 25, 9, p. 1502-1509 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Lymphocyte Count
Monocytes
Lymphocytes
Survival
1 Citation (Scopus)

The definition of IgM multiple myeloma

Schuster, S. R., Rajkumar, S. V., Dispenzieri, A., Morice, W., Moreno Aspitia, A., Ansell, S. M., Kyle, R. & Mikhael, J. R., Aug 2011, In : American Journal of Hematology. 86, 8, p. 718-719 2 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Immunoglobulin M
2010
58 Citations (Scopus)

A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling

Hildebrand, J. M., Luo, Z., Manske, M. K., Price-Troska, T., Ziesmer, S. C., Lin, W., Hostager, B. S., Slager, S. L., Witzig, T. E., Ansell, S. M., Cerhan, J. R., Bishop, G. A. & Novak, A. J., Nov 22 2010, In : Journal of Experimental Medicine. 207, 12, p. 2569-2579 11 p.

Research output: Contribution to journalArticle

B-Cell Activation Factor Receptor
Non-Hodgkin's Lymphoma
Mutation
TNF Receptor-Associated Factor 6
TNF Receptor-Associated Factor 3
99 Citations (Scopus)

A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma

Younes, A., Vose, J. M., Zelenetz, A. D., Smith, M. R., Burris, H. A., Ansell, S. M., Klein, J., Halpern, W., Miceli, R., Kumm, E., Fox, N. L. & Czuczman, M. S., Dec 7 2010, In : British Journal of Cancer. 103, 12, p. 1783-1787 5 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Follicular Lymphoma
TNF-Related Apoptosis-Inducing Ligand Receptors
Staining and Labeling
Disease Progression
26 Citations (Scopus)

A phase II study of 153Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

Dispenzieri, A., Wiseman, G. A., Lacy, M., Hayman, S. R., Kumar, S. K., Buadi, F., Dingli, D. M., Laumann, K. M., Allred, J., Geyer, S. M., Litzow, M. R., Gastineau, D. A., Inwards, D. J., Micallef, I., Ansell, S. M., Porrata, L., Elliott, M. A., Johnston, P. B., Hogan, W. & Gertz, M., Jun 2010, In : American Journal of Hematology. 85, 6, p. 409-413 5 p.

Research output: Contribution to journalArticle

Melphalan
Multiple Myeloma
Radiopharmaceuticals
Hematopoietic Stem Cells
Disease-Free Survival
170 Citations (Scopus)

A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma

Johnston, P. B., Inwards, D. J., Colgan, J. P., Laplant, B. R., Kabat, B. F., Habermann, T. M., Micallef, I., Porrata, L. F., Ansell, S. M., Reeder, C. B., Roy, V. & Witzig, T. E., May 1 2010, In : American Journal of Hematology. 85, 5, p. 320-324 5 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Everolimus
Phosphatidylinositol 3-Kinase
Raptors
Sirolimus

A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma

Johnston, P. B., Inwards, D. J., Colgan, J. P., Laplant, B. R., Kabat, B. F., Habermann, T. M., Micallef, I. N., Porrata, L. F., Ansell, S. M., Reeder, C. B., Roy, V. & Witzig, T. E., May 2010, In : American Journal of Hematology. 85, 5, p. 320-324 5 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Everolimus
Phosphatidylinositol 3-Kinase
Raptors
Sirolimus

Author reply: Flows and flaws in primary CNS lymphoma

Ansell, S. M. & Rajkumar, S. V., Aug 2010, In : Nature Reviews Clinical Oncology. 7, 8

Research output: Contribution to journalArticle

Lymphoma
75 Citations (Scopus)

Autologous stem cell transplant for immunoglobulin light chain amyloidosis: A status report

Gertz, M., Lacy, M., Dispenzieri, A., Hayman, S. R., Kumar, S. K., Dingli, D. M., Ansell, S. M., Gastineau, D. A., Inwards, D. J., Johnston, P. B., Litzow, M. R., Micallef, I., Porrata, L. F., Leung, N., Hogan, W. & Buadi, F. K., Dec 2010, In : Leukemia and Lymphoma. 51, 12, p. 2181-2187 7 p.

Research output: Contribution to journalArticle

Immunoglobulin Light Chains
Amyloidosis
Stem Cells
Transplants
Survival